News

FICAN Science webinar “Precision Therapy for Childhood Leukemia: Improving Outcomes and Reducing Toxicities” on Wed 8 May at 15-16

Read more

Opening Symposium of PCM4EU Academy for Precision Medicine in Oncology 3rd April 2024 accessible both on-site and via video streaming!

Read more

FICAN science webinar on Wed 10.4.2024

Read more

Upcoming FICAN science webinars in 2024 – Save the Dates!

Read more

The Finnish Society for Cell Biology 50th Anniversary on Friday 15th of March in Jyväskylä

Read more

Special lecture Delivering cancer research with impact by Prof. Mark Lawler on Feb 1

Read more

Welcome to the 9th FICAN seminar ‘Cell state transitions and emergence of drug resistance in cancer’ on Wed 31.1.2024 at 15-16 (Teams)

Read more

Save the Date! Finnish Cancer Institute Symposium Kuopio 26-27 Sep 2024

Read more

FICAN South’s Project Call for 2024 is open! The Call for applications closes on 15 January at 15:00

Read more

Merry Christmas & Happy New Year 2024!

Read more

The Finnish Cancer Centre (FICAN) and its coordinating unit are looking for a SENIOR PLANNING OFFICER (PROJECT COORDINATOR) for this ongoing EU project

Read more

Welcome to the 8th FICAN seminar on Wednesday 1.11.2023 at 15-16 “Breast cancer phosphatases”

Read more

Horizon EU Cancer Mission project, PRIME-ROSE, is present at the ESMO Congress 2023

Read more

Open call for Postdoctoral cancer researcher positions at the Finnish Cancer Institute (FCI), Apply by 30.9.2023!

Read more

Welcome to the 7th FICAN seminar on Wednesday 13.9.2023 at 15-16

Read more

Welcome to the 6th FICAN seminar Thursday 25.5.2023 at 15-16

Read more

Finnish Cancer Institute call for two 3-year Research Professor positions open on March 16 – April 16 (12 pm EEST)

Read more

Upcoming FICAN Seminars in 2023 – Save the Dates!

Read more

Welcome to the 4th FICAN seminar Thursday 9.2.2023 at 15-16

Read more

ERN training Workshop in Turku: COMPREHENSIVE GENE PROFILING, MOLECULAR TUMOR BOARD (MTB) AND ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH RARE ADULT CANCERS

Read more

Cancer and Extracellular Vesicles Summer School 1.-2.6.2022, organized by Insitute of Biomedicine & Cancer Research Community, UEF

Read more

SAVE THE DATE: iCAN-FCI Cancer Symposium, September 22-23, Helsinki

Read more

Symposium “Cutting-Edge Implementation of Precision Medicine in Europe” in Karolinska Institutet, Stockholm, Sep 22-23, 2022

Read more

iCAN receives 14 million euro grant to promote development of personalized treatments for cancer

Read more

Cancer IO Training “Translating research into clinical benefit” in January 2022

Read more

SNOG – FiBTRA Symposium, Paja Congress Center Tampere 19-21.5.2022

Read more

FICAN South announces a call for applications for project funding 2022

Read more

FICAN (Comprehensive Cancer Center Finland) and its coordinating unit, is seeking a DIRECTOR OF THE FINNISH CANCER CENTER

Read more

The Finnish Cancer Institute invites applications for Two 2-year postdoctoral cancer researcher positions

Read more

The HERCULES EU project organizes its final webinar on June 14, 2021: Clinical Importance of Drug Resistance Mechanisms in Ovarian Cancer

Read more

Cancer – Breaking Bad Symposium at BioCity Turku, Finland 19-20 August 2021

Read more

A master cancer gene hijacks a “molecular crowbar” to make breast cancer cells invasive

Read more

Mapping the immune landscape of haematological cancers may help to enhance therapies

Read more

10 mil­lion euros in­vest­ment boosts Finnish cap­ab­il­it­ies in cancer im­mun­o­ther­apy

Read more

Closing seminar of the 2019 Scientific Research and Development projects 23.01.2020 at 1-4 pm., Terkko Health Hub Event square, Meilahti

Read more

Mika Mustonen new Director of FICAN South

Read more

The Finnish Cancer Institute has opened nine research positions, FCI-deadline Sept. 12

Read more

Digital health to support precision cancer medicine in ican – a new academy of finland flagship

Read more

HUS Comprehensive Cancer Center and Pfizer begin a partnership to promote clinical trials for cancer drugs

Read more